The sphingosine 1-phosphate receptor modulator FTY720 prevents iodide-induced autoimmune thyroiditis in non-obese diabetic mice

References

• Chiba K. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors. Pharmacol Ther. 2005; 108:308–319.
   PubMed Web of Science ®Google Scholar
• Chiba K, Yanagawa Y, Masubuchi Y, Kataoka H, Kawaguchi T, Ohtsuki M, Hoshino Y. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J Immunol. 1998; 160:5037–5044.
   PubMed Web of Science ®Google Scholar
• Brinkmann V, Davis MD, Heise CE, Albert R, Cottens S, Hof R, Bruns C, Prieschl E, Baumruker T, Hiestand P, Foster CA, Zollinger M, Lynch KR. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem. 2002; 277:21453–21457.
   PubMed Web of Science ®Google Scholar
• Mandala S, Hajdu R, Bergstrom J, Quackenbush E, Xie J, Milligan J, Thornton R, Shei G-J, Card D, Keohane C, Rosenbach M, Hale J, Lynch CL, Rupprecht K, Parsons W, Rosen H. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science. 2002; 296:346–349.
   PubMed Web of Science ®Google Scholar
• Pinschewer DD, Ochsenbein AF, Odermatt B, Brinkmann V, Hengartner H, Zinkernagel RM. FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory. J Immunol. 2000; 164:5761–5770.
   PubMed Web of Science ®Google Scholar
• Brinkmann V, Chen S, Feng L, Pinschewer D, Nikolova Z, Hof R. FTY720 alters lymphocyte homing and protects allografts without inducing general immunosuppression. Transplant Proc. 2001; 33:530–531.
   PubMed Web of Science ®Google Scholar
• Matsuura M, Imayoshi T, Okumoto T. Effect of FTY720, a novel immunosuppressant, on adjuvant- and collagen-induced arthritis in rats. Int J Immunopharmacol. 2000; 22:323–331.
   Web of Science ®Google Scholar
• Kitabayashi H, Isobe M, Watanabe N, Suzuki J-I, Yazaki Y, Sekiguchi M. FTY720 prevents development of experimental autoimmune myocarditis through reduction of circulating lymphocytes. J Cardiovasc Pharmacol. 2000; 35:410–416.
   PubMed Web of Science ®Google Scholar
• Kurose S, Ikeda E, Tokiwa M, Hikita N, Mochizuki M. Effect of FTY720, a novel immunosuppressant, on experimental autoimmune uveoretinitis in rats. Exp Eye Res. 2000; 70:7–15.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhang ZY, Fauser U, Schluesener HJ. FTY720 ameliorates experimental autoimmune neuritis by inhibition of lymphocyte and monocyte infiltration into peripheral nerves. Exp Neurol. 2008; 210:681–690.
   PubMed Web of Science ®Google Scholar
• Fujii T, Tomita T, Kanai T, Nemoto Y, Totsuka T, Sakamoto N, Nakamura T, Tsuchiya K, Okamoto R, Watanabe M. FTY720 suppresses the development of colitis in lymphoid-null mice by modulating the trafficking of colitogenic CD4+ T cells in bone marrow. Eur J Immunol. 2008; 38:3290–3303.
   Google Scholar
• Yang Z, Chen M, Fialkow LB, Ellett JD, Wu R, Brinkmann V, Nadler JL, Lynch KR. The immune modulator FTY720 prevents autoimmune diabetes in non-obese diabetic mice. Clin Immunol. 2003; 107:30–35.
   PubMed Web of Science ®Google Scholar
• Yanagawa Y, Sugahara K, Kataoka H, Kawaguchi T, Masubuchi Y, Chiba K. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo. J Immunol. 1998; 160:5493–5499.
   PubMed Web of Science ®Google Scholar
• Kappos L, Antel J, Comi G, Montalban X, O'Connor P, Polman CH, Haas T, Korn AA, Karlsson G, Radue EW. FTY720 D2201 study group. Oral fingolimod (FTY720) for relapsing multiple sclerosis. N Engl J Med. 2006; 355:1124–1140.
   PubMed Web of Science ®Google Scholar
• Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med. 1996; 335:99–107.
   PubMed Web of Science ®Google Scholar
• Paschke R, Schuppert F, Taton M, Velu T. Intrathyroidal cytokine gene expression profiles in autoimmune thyroiditis. J Endocrinol. 1994; 141:309–315.
   PubMed Web of Science ®Google Scholar
• Ajjan RA, Watson PF, McIntosh RS, Weetman AP. Intrathyroidal cytokine gene expression in Hashimoto's thyroiditis. Clin Exp Immunol. 1996; 105:523–528.
   PubMed Web of Science ®Google Scholar
• Mori K, Yoshida K, Tani J-I, Nakagawa Y, Hoshikawa S, Ozaki H, Ito S. Effects of angiotensin II blockade on the development of autoimmune thyroiditis in non-obese diabetic mice. Clin Immunol. 2008; 126:97–103.
   PubMedGoogle Scholar
• Mori K, Yoshida K, Nakagawa Y, Hoshikawa S, Ozaki H, Ito S. Does rosuvastatin offer therapeutic potential in autoimmune thyroiditis in non-obese diabetic mice?. Clin Immunol. 2009; 130:375–377.
   PubMed Web of Science ®Google Scholar
• Tani J-I, Mori K, Hoshikawa S, Nakazawa T, Satoh J, Nakagawa Y, Ito S, Yoshida K. Prevention of lymphocytic thyroiditis in iodide-treated non-obese diabetic mice lacking interferon regulatory factor-1. Eur J Endocrinol. 2002; 147:809–814.
   PubMed Web of Science ®Google Scholar
• Saboori AM, Rose NR, Butscher WG, Burek CL. Modification of a nonincinerative method for determination of iodine in iodoproteins. Anal Biochem. 1993; 214:335–338.
   PubMedGoogle Scholar
• Kong Y, David CS, Giraldo AA, Elrehewy M, Rose NR. Regulation of autoimmune response to mouse thyroglobulin: Influence of H-2D-end genes. J Immunol. 1979; 123:15–18.
   PubMed Web of Science ®Google Scholar
• Hozumi Y, Kobayashi E, Miyata M, Fujimura A. Immunotherapy for experimental rat autoimmune thyroiditis using a novel immunosuppressant, FTY720. Life Sci. 1999; 65:1739–1745.
   Google Scholar
• Papanastasiou L, Vatalas IA, Koutras DA, Mastorakos G. Thyroid autoimmunity in the current iodine environment. Thyroid. 2007; 17:729–739.
   Google Scholar
• Vladutiu AO. Effect of cyclosporine on experimental autoimmune thyroiditis in mice. Transplantation. 1983; 35:518–520.
   Google Scholar
• Paterson PY, Drobish DG. Reversal of experimental allergic thyroiditis in cyclophosphamide-treated rats. Clin Exp Immunol. 1975; 20:125–129.
   PubMed Web of Science ®Google Scholar
• Kappos L, Radue E-W, O'Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C, Leyk M, Zhang-Auberson L, Burtin P, The FREEDOM study group. A placebo-controlled trial of oral fingolimod (FTY720) in relapsing multiple sclerosis. N Engl J Med. 2010; 362:387–401.
   PubMed Web of Science ®Google Scholar
• Champion BR, Rayner DC, Byfield PG, Page KR, Chan CT, Roitt IM. Critical role of iodination for T cell recognition of thyroglobulin in experimental murine thyroid autoimmunity. J Immunol. 1987; 139:3665–3670.
   PubMed Web of Science ®Google Scholar
• Ebner SA, Lueprasitsakul W, Alex S, Fang SL, Appel MC, Braverman LE. Iodine content of rat thyroiglobulin affects its antigenicity in inducing lymphocytic thyroiditis in the BB/Wor rat. Autoimmunity. 1992; 13:209–214.
   PubMed Web of Science ®Google Scholar
• Rasooly L, Rose NR, Saboori AM, Ladenson PW, Burek CL. Iodine is essential for human T cell recognition of human thyroglobulin. Autoimmunity. 1998; 27:213–219.
   PubMed Web of Science ®Google Scholar
• Hofmann M, Brinkmann V, Zerwes H-G. FTY720 preferentially depletes naïve T cells from peripheral and lymphoid organs. Int Immunopharmacol. 2006; 6:1902–1910.
   PubMed Web of Science ®Google Scholar
• Jin Z, Mori K, Fujimori K, Hoshikawa S, Tani J-I, Satoh J, Ito S, Satomi S, Yoshida K. Experimental autoimmune thyroiditis in non-obese diabetic mice lacking interferon regulatory factor-1. Clin Immunol. 2004; 113:187–192.
   PubMedGoogle Scholar
• Yagi H, Kamba R, Chiba K, Soga H, Yaguchi K, Nakamura M, Itoh T. Immunosuppressant FTY720 inhibits thymocyte emigration. Eur J Immunol. 2000; 30:1435–1444.
   PubMed Web of Science ®Google Scholar
• Müller H, Hofer S, Kaneider N, Neuwirt H, Mosheimer B, Mayer G, Konwalinka G, Heufler C, Tiefenthaler M. The immunomodulator FTY720 interferes with effector functions of human monocyte-derived dendritic cells. Eur J Immunol. 2005; 35:533–545.
   PubMed Web of Science ®Google Scholar
• Sawicka E, Dubois G, Jarai G, Edwards M, Thomas M, Nicholls A, Albert R, Newson C, Brinkmann V, Walker C. The sphingosine 1-phosphate receptor agonist FTY720 differentially affects the sequestration of CD4+/CD25+ T-regulatory cells and enhances their functional activity. J Immunol. 2005; 175:7973–7980.
   PubMed Web of Science ®Google Scholar